Korean J Fam Pract 2020; 10(5): 348-354  https://doi.org/10.21215/kjfp.2020.10.5.348
Prevalence of Hyperuricemia and Its Association with Obesity in Korean Adults: Analysis Based on 2018 Korea National Health and Nutrition Examination Survey
Jae-Ho Chun, Jung-Hwan Kim, John A. Linton*
Department of Family Medicine, Yonsei University College of Medicine, Seoul, Korea
John A. Linton
Tel: +82-2-2228-2331, Fax: +82-2-362-2473
E-mail: yohan@yuhs.ac
ORCID: https://orcid.org/0000-0001-8000-3049
Received: May 8, 2020; Revised: June 22, 2020; Accepted: July 15, 2020; Published online: October 20, 2020.
© The Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: This study aimed to analyze the association between the prevalence of hyperuricemia and obesity in Korean adults.
Methods: The participants included 5,922 adults from the 2018 Korea National Health and Nutrition Examination Survey. We examined the relationship between obesity status and serum uric acid levels using a chi-square test and multiple logistic regression.
Results: There was an increase in the prevalence of hyperuricemia with higher body mass index (P<0.001 and P=0.003, respectively). Both male and female in a higher obesity class also had a higher odds ratio for the prevalence of hyperuricemia (P<0.001). This trend remained consistent after adjusting for all confounding factors. The obesity class III group was found to be associated with the highest risk of hyperuricemia.
Conclusion: In this study, we found that hyperuricemia was significantly associated with obesity in Korean adults. In a clinical setting, this finding presents objective data for more aggressive management and ultimate prevention of obesity.
Keywords: Hyperuricemia; Uric Acid; Obesity; Body Mass Index; Adult
References
  1. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des 2005; 11: 4145-51.
    Pubmed CrossRef
  2. Schlesinger N. Dietary factors and hyperuricaemia. Curr Pharm Des 2005;11: 4133-8.
    Pubmed CrossRef
  3. Terkeltaub RA. Clinical practice. Gout. N Engl J Med 2003; 349: 1647-55.
    Pubmed CrossRef
  4. Remedios C, Shah M, Bhasker AG, Lakdawala M. Hyperuricemia: a reality in the Indian obese. Obes Surg 2012; 22: 945-8.
    Pubmed CrossRef
  5. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63: 3136-41.
    Pubmed CrossRef
  6. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004; 4: 9.
    Pubmed KoreaMed CrossRef
  7. Nakanishi N, Yoshida H, Nakamura K, Suzuki K, Tatara K. Predictors for development of hyperuricemia: an 8-year longitudinal study in middleaged Japanese men. Metabolism 2001; 50: 621-6.
    Pubmed CrossRef
  8. Tanaka K, Ogata S, Tanaka H, Omura K, Honda C; Osaka Twin Research Group, Hayakawa K. The relationship between body mass index and uric acid: a study on Japanese adult twins. Environ Health Prev Med 2015; 20:347-53.
    Pubmed KoreaMed CrossRef
  9. Huda N, Hossain S, Rahman M, Karim MR, Islam K, Mamun AA, et al. Elevated levels of plasma uric acid and its relation to hypertension in arsenicendemic human individuals in Bangladesh. Toxicol Appl Pharmacol 2014;281: 11-8.
    Pubmed CrossRef
  10. Zhang J, Zhang Y, Deng W, Chen B. Elevated serum uric acid is associated with angiotensinogen in obese patients with untreated hypertension. J Clin Hypertens (Greenwich) 2014; 16: 569-74.
    Pubmed CrossRef
  11. Song JS, Jun JB. Korean guidelines for tailored management of gout. J Rheum Dis 2013; 20: 280-5.
    CrossRef
  12. Becker MA, Jolly M. Hyperuricemia and associated diseases. Rheum Dis Clin North Am 2006; 32: 275-93, v-vi.
    Pubmed CrossRef
  13. Chen MY, Zhao CC, Li TT, Zhu Y, Yu TP, Bao YQ, et al. Serum uric acid levels are associated with obesity but not cardio-cerebrovascular events in Chinese inpatients with type 2 diabetes. Sci Rep 2017; 7: 40009.
    Pubmed KoreaMed CrossRef
  14. Kim Y, Kang J, Kim GT. Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample. Clin Rheumatol 2018; 37: 2529-38.
    Pubmed CrossRef
  15. Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S. Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 2004; 27: 227-33.
    Pubmed CrossRef
  16. Yang J, Liu Z, Zhang C, Zhao Y, Sun S, Wang S, et al. The prevalence of hyperuricemia and its correlates in an inland Chinese adult population, urban and rural of Jinan. Rheumatol Int 2013; 33: 1511-7.
    Pubmed CrossRef
  17. Yamanaka H. Gout and hyperuricemia in young people. Curr Opin Rheumatol 2011; 23: 156-60.
    Pubmed CrossRef
  18. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69: 928-33.
    Pubmed CrossRef
  19. Khang YH, Yun SC. Trends in general and abdominal obesity among Korean adults: findings from 1998, 2001, 2005, and 2007 Korea National Health and Nutrition Examination Surveys. J Korean Med Sci 2010; 25: 1582-8.
    Pubmed KoreaMed CrossRef
  20. Han E, Kim TH, Powell LM. Beverage consumption and individual-level associations in South Korea. BMC Public Health 2013; 13: 195.
    Pubmed KoreaMed CrossRef
  21. Park HS, Oh SW, Cho SI, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 2004; 33: 328-36.
    Pubmed CrossRef
  22. Cohen E, Krause I, Fraser A, Goldberg E, Garty M. Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel. Isr Med Assoc J 2012; 14: 676-80.
    Pubmed
  23. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363: 1277-81.
    CrossRef
  24. Brand FN, McGee DL, Kannel WB, Stokes J 3rd, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol 1985; 121: 11-8.
    Pubmed CrossRef
  25. Yu S, Yang H, Guo X, Zhang X, Zhou Y, Ou Q, et al. Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities. Clin Rheumatol 2016; 35:1207-15.
    Pubmed CrossRef
  26. Ryu S, Chang Y, Zhang Y, Kim SG, Cho J, Son HJ, et al. A cohort study of hyperuricemia in middle-aged South Korean men. Am J Epidemiol 2012; 175:133-43.
    Pubmed CrossRef
  27. Palmer TM, Nordestgaard BG, Benn M, Tybjærg-Hansen A, Davey Smith G, Lawlor DA, et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ 2013; 347: f4262.
    Pubmed KoreaMed CrossRef
  28. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474-80.
    Pubmed CrossRef

This Article


Author ORCID Information

Services
Social Network Service

e-submission

Archives